Because additional common genetic variations may influence PAH development in patients either with or without a BMPR2 mutation, we decided to include idiopathic and heritable PAH (I/HPAH) patients carrying BMPR2 mutations in our GWAS. Here, BMPR2 is linked to pulmonary arterial hypertension.